Jian-Rong Xu

Targeting Microglial Receptors for Alzheimer’s Disease: Translational Barriers from Bench to Bedside

Preclinical and clinical progress in therapeutics targeting microglial receptors are summarized; critical translational bottlenecks are analyzed; potential strategies including precision delivery, humanized experimental systems, and biomarker-forward trial designs are discussed, with the goal of supporting rigorously d...